BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
51.14
-0.04 (-0.08%)
At close: Aug 15, 2025, 2:39 PM
BBIO Gamma Exposure By Expiry
The total Gamma Exposure (GEX) for BBIO across all expirations is 28,966.99 shares per 1% move, with 43,259.18 from calls and 14,292.19 from puts. The put-call GEX ratio of 0.33 shows call-heavy positioning, potentially creating volatility as market makers hedge by selling into strength and buying weakness. The highest gamma concentration is at the Jan 16, 26 expiration with 22,789.98 net GEX, which may act as a magnet point for price action. Near-term exposure for Sep 19, 25 suggests possible volatility from negative gamma effects.
BBIO GEX Table
| Expiry Date | Call GEX | Put GEX | Net GEX | P/C GEX |
|---|---|---|---|---|
| Sep 19, 25 | 5,238.19 | -7,114.65 | -1,876.46 | 1.36 |
| Oct 17, 25 | 0 | 0 | 0 | n/a |
| Nov 21, 25 | 5,775.43 | -2,198.69 | 3,576.74 | 0.38 |
| Jan 16, 26 | 26,706.81 | -3,916.83 | 22,789.98 | 0.15 |
| Feb 20, 26 | 2,002.33 | -34.94 | 1,967.39 | 0.02 |
| Jul 17, 26 | 3,007.53 | -1,008 | 1,999.53 | 0.34 |
| Jan 15, 27 | 528.89 | -19.08 | 509.81 | 0.04 |